These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
591 related articles for article (PubMed ID: 29060925)
21. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis. Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760 [TBL] [Abstract][Full Text] [Related]
22. Calculated indices of volatile organic compounds (VOCs) in exhalation for lung cancer screening and early detection. Chen X; Muhammad KG; Madeeha C; Fu W; Xu L; Hu Y; Liu J; Ying K; Chen L; Yurievna GO Lung Cancer; 2021 Apr; 154():197-205. PubMed ID: 33653598 [TBL] [Abstract][Full Text] [Related]
23. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening. Zhong X; Li D; Du W; Yan M; Wang Y; Huo D; Hou C Anal Bioanal Chem; 2018 Jun; 410(16):3671-3681. PubMed ID: 29654337 [TBL] [Abstract][Full Text] [Related]
24. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis. Sun X; Shao K; Wang T Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028 [TBL] [Abstract][Full Text] [Related]
25. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121 [TBL] [Abstract][Full Text] [Related]
26. Chemiresistive Sensor Array with Nanostructured Interfaces for Detection of Human Breaths with Simulated Lung Cancer Breath VOCs. Shang G; Dinh D; Mercer T; Yan S; Wang S; Malaei B; Luo J; Lu S; Zhong CJ ACS Sens; 2023 Mar; 8(3):1328-1338. PubMed ID: 36883832 [TBL] [Abstract][Full Text] [Related]
28. Detection of cancer through exhaled breath: a systematic review. Krilaviciute A; Heiss JA; Leja M; Kupcinskas J; Haick H; Brenner H Oncotarget; 2015 Nov; 6(36):38643-57. PubMed ID: 26440312 [TBL] [Abstract][Full Text] [Related]
29. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers. Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102 [TBL] [Abstract][Full Text] [Related]
30. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study. Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569 [TBL] [Abstract][Full Text] [Related]
31. Breath carbonyl compounds as biomarkers of lung cancer. Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567 [TBL] [Abstract][Full Text] [Related]
32. Diagnosis by Volatile Organic Compounds in Exhaled Breath in Exhaled Breath from Patients with Gastric and Colorectal Cancers. Chung J; Akter S; Han S; Shin Y; Choi TG; Kang I; Kim SS Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613569 [TBL] [Abstract][Full Text] [Related]
33. Breath testing as potential colorectal cancer screening tool. Amal H; Leja M; Funka K; Lasina I; Skapars R; Sivins A; Ancans G; Kikuste I; Vanags A; Tolmanis I; Kirsners A; Kupcinskas L; Haick H Int J Cancer; 2016 Jan; 138(1):229-36. PubMed ID: 26212114 [TBL] [Abstract][Full Text] [Related]
34. Fecal volatile organic compounds for early detection of colorectal cancer: where are we now? Bosch S; Berkhout DJ; Ben Larbi I; de Meij TG; de Boer NK J Cancer Res Clin Oncol; 2019 Jan; 145(1):223-234. PubMed ID: 30554400 [TBL] [Abstract][Full Text] [Related]
35. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers. Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711 [TBL] [Abstract][Full Text] [Related]
36. Prediction of breast cancer risk with volatile biomarkers in breath. Phillips M; Cataneo RN; Cruz-Ramos JA; Huston J; Ornelas O; Pappas N; Pathak S Breast Cancer Res Treat; 2018 Jul; 170(2):343-350. PubMed ID: 29569019 [TBL] [Abstract][Full Text] [Related]
37. Geographical variation in the exhaled volatile organic compounds. Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568 [TBL] [Abstract][Full Text] [Related]
38. Detecting Colorectal Adenomas and Cancer Using Volatile Organic Compounds in Exhaled Breath: A Proof-of-Principle Study to Improve Screening. Cheng HR; van Vorstenbosch RWR; Pachen DM; Meulen LWT; Straathof JWA; Dallinga JW; Jonkers DMAE; Masclee AAM; Schooten FV; Mujagic Z; Smolinska A Clin Transl Gastroenterol; 2022 Nov; 13(11):e00518. PubMed ID: 35981245 [TBL] [Abstract][Full Text] [Related]
39. Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation. Wang C; Dong R; Wang X; Lian A; Chi C; Ke C; Guo L; Liu S; Zhao W; Xu G; Li E Sci Rep; 2014 Dec; 4():7312. PubMed ID: 25482491 [TBL] [Abstract][Full Text] [Related]
40. Exhaled breath biopsy: a new cancer detection paradigm. Abderrahman B Future Oncol; 2019 May; 15(15):1679-1682. PubMed ID: 30977676 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]